Article

PDGFRA amplification could be a poor prognostic factor of advanced undifferentiated pleomorphic sarcoma in a comprehensive genomic profiling cohort

2026-01-22

Abstract excerpt

<title>Abstract</title> <p> Background Undifferentiated pleomorphic sarcoma (UPS) is the most common pleomorphic sarcoma, and its genomic landscape has been analyzed, albeit in small numbers. This study aimed to clarify the relationship between gene variants and the prognosis of patients with advanced UPS. Methods This retrospective cohort study was conducted to analyze the data of patients with advanced UPS u...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8b1c4a79-9346-5312-8bd1-7cae68f26947
DOI: 10.21203/rs.3.rs-8360517/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

PDGFRA amplification could be a poor prognostic factor of advanced undifferentiated pleomorphic sarcoma in a comprehensive genomic profiling cohortDOI 10.21203/rs.3.rs-8360517/v1Read

Systematic screening identifies a 2‐gene signature as a high‐potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcomaSemantic proximity Read

Heterogeneity of Undifferentiated Pleomorphic Sarcoma Genetic Landscape: Is There a Room for Targeted Therapy?Semantic proximity Read

Pathogenic and Targetable Genetic Alterations in Resected Recurrent Undifferentiated Pleomorphic Sarcomas Identified by Targeted Next-generation SequencingSemantic proximity Read

Undifferentiated pleomorphic sarcoma with co-existence of KRAS/PIK3CA mutations.Semantic proximity Read

Transcriptomic profiles of myxofibrosarcoma and undifferentiated pleomorphic sarcoma correlate with clinical and genomic features.Semantic proximity Read

Characterization and clinical relevance of PDGFRA pathway copy number variation gains across human cancers.Semantic proximity Read

Primary cardiac undifferentiated pleomorphic sarcoma is associated with TP53 mutation during lack of MDM2 amplification, and targeted sequencing analysis reveals potentially actionable targets.Semantic proximity Read

Genomic Profiling of Sarcomas: A Promising Weapon in the Therapeutic ArsenalSemantic proximity Read

A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosisSemantic proximity Read

Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma.Semantic proximity Read

Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcomaSemantic proximity Read

Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of boneSemantic proximity Read